SciSure is a platform for managing laboratory operations end-to-end, built for scientific organizations. It brings together ELN, LIMS, and Health & Safety tools so teams can document experiments, track samples, manage chemical inventory, and maintain compliance workflows that are structured and audit-ready.
By replacing fragmented systems with a single governed platform, SciSure helps organizations improve reproducibility, gain clearer operational visibility, and scale lab operations with less risk.
Learn more

Revaly is built to solve one of the most costly and overlooked problems in subscription commerce: legitimate payments failing for preventable reasons. Its end-to-end Payment Performance Management platform leverages machine learning, issuer intelligence, and ecosystem data to elevate approval rates starting from the very first transaction attempt. The system automatically detects issues such as mistyped card numbers, routing mismatches, and metadata errors before a customer ever checks out. When payments do fail, Revaly uses a sophisticated retry engine that studies customer behavior, card network patterns, and historical success windows to recover revenue without damaging relationships. Businesses across industries report dramatic improvements—from 34% to over 50% increases in recovered payments—demonstrating the compound value of consistent, optimized approvals. Revaly’s integration ecosystem makes adoption frictionless, connecting seamlessly with CRMs, billing systems, payment gateways, and processors already in use. The platform not only protects revenue but stabilizes growth by reducing churn that comes from unintentional payment failures. Leadership teams gain visibility into payment performance metrics that go far beyond authorization rates, revealing hidden revenue opportunities and operational inefficiencies. As a result, companies can build smarter billing strategies and deliver a more reliable experience for customers. Revaly becomes a trusted partner in improving profitability, ensuring that when a customer says “yes,” the payment system does too.
Learn more
Eidogen-Sertanty Target Informatics Platform (TIP)
Eidogen-Sertanty's Target Informatics Platform (TIP) is a groundbreaking structural informatics system and knowledgebase that allows researchers to investigate the druggable genome from a structural perspective. By leveraging the growing abundance of experimental protein structure data, TIP transforms structure-based drug discovery from a constrained, low-throughput endeavor into an energetic and information-rich scientific field. It is meticulously crafted to bridge the gap between bioinformatics and cheminformatics, equipping drug discovery scientists with a treasure trove of insights that are not just distinctive but also greatly complementary to the existing data from conventional bio- and cheminformatics tools. The platform's advanced integration of structural data management and sophisticated target-to-lead analysis capabilities significantly improves each stage of the drug discovery journey. Through TIP, researchers gain a powerful tool that enables them to better understand the complexities of drug development, fostering more informed decision-making throughout the process. Ultimately, this innovative approach positions scientists to unlock new therapeutic avenues in the ever-evolving landscape of drug discovery.
Learn more
BIOiSIM
BIOiSIMTM is a revolutionary virtual drug development engine that offers significant advantages to the pharmaceutical industry by adeptly identifying drug compounds with strong potential for addressing specific diseases. Our range of translational solutions is designed to align with the unique requirements of your pre-clinical and clinical projects. At the heart of these offerings lies our trustworthy and validated BIOiSIMTM platform, which supports research on small molecules, large molecules, and viruses. Utilizing advanced models, this platform draws on data from thousands of compounds across seven different species, delivering a robustness that is rare in the industry. With a keen focus on human outcomes, it incorporates a translatability engine that efficiently translates insights between species. Importantly, the BIOiSIMTM platform is applicable before initiating preclinical animal trials, enabling earlier insights and significantly lowering costs linked to outsourced testing. This cutting-edge methodology not only improves efficiency but also hastens the overall drug development timeline, ultimately aiding the search for effective therapies. By streamlining the process, BIOiSIMTM has the potential to contribute to significant advancements in medicine.
Learn more